Compare ANTX & MINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANTX | MINE |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | Canada |
| Employees | N/A | 9 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.8M | 163.8M |
| IPO Year | 2022 | N/A |
| Metric | ANTX | MINE |
|---|---|---|
| Price | $4.71 | $2.52 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 442.7K | 24.1K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $2.16 |
| 52 Week High | $6.91 | $4.45 |
| Indicator | ANTX | MINE |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 46.69 |
| Support Level | $3.91 | $2.16 |
| Resistance Level | $5.13 | $2.87 |
| Average True Range (ATR) | 0.35 | 0.19 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 51.28 | 37.50 |
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Mayfair Gold Corp is a mineral exploration company that is engaged in the acquisition and exploration of mineral properties. It has one material mineral property, the Fenn-Gib Gold Property, located in the Guibord, Munro, Michaud, and McCool Townships in northeast Ontario, which is in the exploration stage.